ArticleClinical cancer research : an official journal of the American Association for Cancer Research2012

Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemoprevention.

Michelle A T Hildebrandt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.